| ²é¿´: 1059 | »Ø¸´: 6 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
ΪÄãÇ鶯½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
°ïæ·ÒëÒ»¶ÎÕªÒª£¬Ð»Ð»
|
|
|
Ö÷¶¯°ÐÏò¸øÒ©ÖÎÁƷΰ©µÄÑо¿½øÕ¹¡£Ä¿Ç°£¬Íâ¿ÆÕïÁƼ¼Êõ¼°»¯ÁÆ¡¢·ÅÁƵÈ×÷Ϊ·Î°©µÄÖ÷ÒªÖÎÁÆÊֶΣ¬ËäÈ»¶Ô·Î°©µÄÖÎÁÆÆðµ½Ò»¶¨Ð§¹û£¬µ«¶Ô»¼Õß³¤ÆÚÉú´æµÄ¸ÄÉÆ³Ì¶È½ÏС¡£°ÐÏòÖÎÁƼ¼ÊõÒòÆä°²È«¡¢¸ßЧ¡¢µÍ¶¾µÄÖÎÁÆÐ§¹û¶ø³ÉΪµ±Ç°·Î°©Ñо¿µÄÈȵãÖ®Ò»¡£±¾ÎĽéÉÜÁËĿǰÖ÷¶¯°ÐÏòÖÎÁƷΰ©¹ý³ÌÖеĸ÷Àà°Ð·Ö×Ó¼°°ÐÏòºÍżÁª»úÀí£¬²ûÊöÁËÅäÌå-ÊÜÌå½éµ¼¡¢¿¹Ô-¿¹Ìå½éµ¼Ôڷΰ©°ÐÏòÖÎÁÆÖеÄÑо¿½øÕ¹¡£×îºó£¬¶ÔÆäÁÙ´²Ó¦ÓýøÐÐÁËÕ¹Íû¡£ @wenzi6337 |
» ²ÂÄãϲ»¶
085600 ²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
»¯Ñ§¹¤³Ì085602 305·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸£ºÎ÷±±´óѧ£¬Ó¢Ò»ÊýÒ»408-284·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´

ΪÄãÇ鶯
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 393.4
- É¢½ð: 10
- ºì»¨: 16
- ɳ·¢: 3
- Ìû×Ó: 824
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 1398029
- ×¢²á: 2011-09-11
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ó×é×°Ó볬·Ö×ӽṹ

3Â¥2012-07-11 10:25:38
lan321
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1261.3
- ºì»¨: 3
- Ìû×Ó: 149
- ÔÚÏß: 40.4Сʱ
- ³æºÅ: 989721
- ×¢²á: 2010-04-05
- ÐÔ±ð: GG
- רҵ: ÆäËûÎÞ»ú·Ç½ðÊô²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
sltmac: ½ð±Ò+1 2012-07-11 13:16:17
ΪÄãÇ鶯: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, ллÄã°¡£¬·ÒëµÄÒ²²»´í£¬²»¹ýÓеÀºÃÏñ¾ÍÕâô·ÒëµÄ£¬»¹ÊÇллÁË 2012-07-11 22:32:43
ΪÄãÇ鶯: ½ð±Ò+5, ллÀ² 2012-07-11 22:34:50
sltmac: ½ð±Ò+1 2012-07-11 13:16:17
ΪÄãÇ鶯: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, ллÄã°¡£¬·ÒëµÄÒ²²»´í£¬²»¹ýÓеÀºÃÏñ¾ÍÕâô·ÒëµÄ£¬»¹ÊÇллÁË 2012-07-11 22:32:43
ΪÄãÇ鶯: ½ð±Ò+5, ллÀ² 2012-07-11 22:34:50
| Active targeting of drug treatment for lung cancer research progress. At present, surgical treatment techniques and chemotherapy, and radiotherapy as the main treatment of lung cancer, the treatment of lung cancer play a certain effect, but a smaller degree of improvement in patients with long-term survival. Targeted therapy technology because of its safe, efficient, and low toxicity of the treatment effect and become one of the hotspots of the current lung cancer research. This article describes the various types of target molecules in the active targeted therapy of lung cancer process and targeting and coupling mechanism, described the progress of the ligand - receptor-mediated, antigen - antibody-mediated targeted therapy of lung cancer. Finally, the clinical application prospect. |

2Â¥2012-07-10 20:31:57
ΪÄãÇ鶯
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 393.4
- É¢½ð: 10
- ºì»¨: 16
- ɳ·¢: 3
- Ìû×Ó: 824
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 1398029
- ×¢²á: 2011-09-11
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ó×é×°Ó볬·Ö×ӽṹ

4Â¥2012-07-11 14:43:37
wenzi6337
ľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 6
- Ó¦Öú: 27 (СѧÉú)
- ½ð±Ò: 3267.6
- É¢½ð: 196
- ºì»¨: 7
- ɳ·¢: 1
- Ìû×Ó: 1364
- ÔÚÏß: 413.8Сʱ
- ³æºÅ: 716576
- ×¢²á: 2009-03-06
- ÐÔ±ð: GG
- רҵ: Ö²ÎïÉúÀíÓëÉú»¯
5Â¥2012-07-11 18:27:56














»Ø¸´´ËÂ¥
Çó·Ò룬»ò°Ñ¶þÂ¥µÄ·Òë¸ÄµÄÍêÃÀһЩ£¬½ð±Ò¿ÉÒÔÔÙ¼Ó°¡£¬Çó¸÷λÁË